Search results
Results From The WOW.Com Content Network
The Job Creation Act (Indonesian: Undang-Undang Cipta Kerja), officially Act Number 11/2020 on Job Creation (Undang-Undang Nomor 11 Tahun 2020 Tentang Cipta Kerja, or UU 11/2020), is a bill that was passed on 5 October 2020 by Indonesia's House of Representatives, with the aim of creating jobs and raising foreign and domestic investment by reducing regulatory requirements for business permits ...
Bahasa Indonesia: Rancangan Undang-Undang Republik Indonesia tentang Cipta Kerja (dikenal juga sebagai UU Sapu Jagat) dengan total 488 halaman, atau 814 halaman setelah disertai penjelasan, yang telah ditandatangani oleh Azis Syamsuddin.
Bahasa Indonesia: UU ini mengatur mengenai penetapan Peraturan Pemerintah Pengganti Undang-Undang Nomor 2 Tahun 2022 tentang Cipta Kerja (Lembaran Negara Republik Indonesia Tahun 2022 Nomor 238, Tambahan Lembaran Negara Republik Indonesia Nomor 6841) ditetapkan menjadi Undang-Undang dan melampirkannya sebagai bagian yang tidak terpisahkan dari Undang-Undang ini.
Some of the biggest brands in America, including Amazon, Meta, Walmart and McDonald’s, have recently changed or ended their diversity, equity and inclusion (DEI) programs. But e.l.f. Beauty, a ...
The 2023 Omnibus Law on Job Creation, officially the Act No. 6 of 2023 On the Enaction of Government Regulation in Lieu of Act No. 2 of 2022 On Job Creation into Act (Indonesian: Undang-Undang Nomor 6 Tahun 2023 Tentang Penetapan Peraturan Pemerintah Pengganti Undang-Undang Nomor 2 Tahun 2022 Tentang Cipta Kerja Menjadi Undang-Undang) is an Indonesian act which made the Government Regulation ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
The following other wikis use this file: Usage on id.wikisource.org Indeks:UU Nomor 11 Tahun 2020 tentang Cipta Kerja.pdf; Halaman:UU Nomor 11 Tahun 2020 tentang Cipta Kerja.pdf/1
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.